Literature DB >> 12592262

Oxytocin-induced desensitization of the oxytocin receptor.

Christopher Robinson1, Ralph Schumann, Peisheng Zhang, Roger C Young.   

Abstract

OBJECTIVE: The purpose of this study was to characterize the oxytocin-induced desensitization of oxytocin-stimulated rises of intracellular calcium in cultured human myocytes. STUDY
DESIGN: Culture lines were begun from biopsy specimens of myometrium that had been obtained from women who underwent low transverse cesarean deliveries. Fluorescence changes of calcium green-1 were used to demonstrate the rises of intracellular free calcium. Cells were exposed to 10 nmol/L oxytocin for 1 to 6 hours before the experimentation, allowed to rest for 10 minutes, and then tested for the fluorescence increases that resulted from exposure to 10 nmol/L oxytocin and micromol/L prostaglandin F(2)(alpha). Subpopulations were defined as type 1 (responded to both oxytocin and prostaglandin F(2)(alpha)), type 2 (responded only to oxytocin), type 3 (responded only to prostaglandin F(2)(alpha)), or type 4 (responded to neither). The distribution of the subpopulations of cells was assessed by the determination of the response of every cell in every experimental run.
RESULTS: Pretreatment with oxytocin resulted in a decrease in the percentage of cells that responded to subsequent oxytocin exposure. The decrease was dependent on the duration of oxytocin exposure and was well fit with the Boltzmann sigmoid function. The duration of oxytocin exposure that yielded half-inactivation was 4.2 hours. Without oxytocin pretreatment, the distribution of subpopulations were 37.0% +/- 18.0% (type 1), 23.1% +/- 11.5% (type 2), 12.6% +/- 8.0% (type 3), and 27.3% +/- 22.9% (type 4). After 6 hours of oxytocin pretreatment, the percentage of type 1 and type 2 cells decreased to 2.4% +/- 3.8% and 2.6% +/- 2.4%, respectively, although the percentage of type 3 and type 4 cells increased to 20.4% +/- 18.9% and 74.6% +/- 22.1%, respectively.
CONCLUSION: Oxytocin-induced desensitization of myocytes to oxytocin stimulation occurred over a clinically relevant time frame (4.2 hours). Continued responsiveness of the cells to prostaglandin F(2)(alpha) stimulation after 6 hours of oxytocin pretreatment indicated that postreceptor signaling pathways were maintained, which indicates that the oxytocin receptor likely is involved in the mechanism of myocyte desensitization to oxytocin stimulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592262     DOI: 10.1067/mob.2003.22

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

1.  Intrapartum synthetic oxytocin reduce the expression of primitive reflexes associated with breastfeeding.

Authors:  Miguel A Marín Gabriel; Ibone Olza Fernández; Ana M Malalana Martínez; Carmen González Armengod; Valeria Costarelli; Isabel Millán Santos; Aurora Fernández-Cañadas Morillo; Pilar Pérez Riveiro; Francisco López Sánchez; Lourdes García Murillo
Journal:  Breastfeed Med       Date:  2015-03-18       Impact factor: 1.817

2.  Endogenous oxytocin inhibits hypothalamic corticotrophin-releasing hormone neurones following acute hypernatraemia.

Authors:  Dipanwita Pati; Scott W Harden; Wanhui Sheng; Kyle B Kelly; Annette D de Kloet; Eric G Krause; Charles J Frazier
Journal:  J Neuroendocrinol       Date:  2020-03-05       Impact factor: 3.627

3.  Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder.

Authors:  Martina Sgritta; Sean W Dooling; Shelly A Buffington; Eric N Momin; Michael B Francis; Robert A Britton; Mauro Costa-Mattioli
Journal:  Neuron       Date:  2018-12-03       Impact factor: 17.173

4.  Use of oxytocin during early stages of labor and its effect on active management of third stage of labor.

Authors:  Claudio G Sosa; Fernando Althabe; José M Belizan; Pierre Buekens
Journal:  Am J Obstet Gynecol       Date:  2010-12-08       Impact factor: 8.661

5.  Regulation of oxytocin receptor responsiveness by G protein-coupled receptor kinase 6 in human myometrial smooth muscle.

Authors:  Jonathon M Willets; Paul J Brighton; Rajendra Mistry; Gavin E Morris; Justin C Konje; R A John Challiss
Journal:  Mol Endocrinol       Date:  2009-05-07

Review 6.  Therapeutic potential of β-arrestin- and G protein-biased agonists.

Authors:  Erin J Whalen; Sudarshan Rajagopal; Robert J Lefkowitz
Journal:  Trends Mol Med       Date:  2010-12-21       Impact factor: 11.951

7.  Are we using right dose of oxytocin?

Authors:  D Devikarani; Ss Harsoor
Journal:  Indian J Anaesth       Date:  2010-09

8.  Poor spontaneous and oxytocin-stimulated contractility in human myometrium from postdates pregnancies.

Authors:  Sarah Arrowsmith; Siobhan Quenby; Andrew Weeks; Theodor Burdyga; Susan Wray
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

Review 9.  Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review.

Authors:  Vilda Baliuliene; Migle Vitartaite; Kestutis Rimaitis
Journal:  Int J Environ Res Public Health       Date:  2021-05-10       Impact factor: 4.614

10.  Induction of labor and risk of postpartum hemorrhage in low risk parturients.

Authors:  Imane Khireddine; Camille Le Ray; Corinne Dupont; René-Charles Rudigoz; Marie-Hélène Bouvier-Colle; Catherine Deneux-Tharaux
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.